155 related articles for article (PubMed ID: 11016659)
1. Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.
Weber D; Klomp HJ; Czubayko F; Wellstein A; Juhl H
Cancer Res; 2000 Sep; 60(18):5284-8. PubMed ID: 11016659
[TBL] [Abstract][Full Text] [Related]
2. Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients.
Klomp HJ; Zernial O; Flachmann S; Wellstein A; Juhl H
Clin Cancer Res; 2002 Mar; 8(3):823-7. PubMed ID: 11895915
[TBL] [Abstract][Full Text] [Related]
3. Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach.
Malerczyk C; Schulte AM; Czubayko F; Bellon L; Macejak D; Riegel AT; Wellstein A
Gene Ther; 2005 Feb; 12(4):339-46. PubMed ID: 15496960
[TBL] [Abstract][Full Text] [Related]
4. Expression of pleiotrophin, an embryonic growth and differentiation factor, in rheumatoid arthritis.
Pufe T; Bartscher M; Petersen W; Tillmann B; Mentlein R
Arthritis Rheum; 2003 Mar; 48(3):660-7. PubMed ID: 12632418
[TBL] [Abstract][Full Text] [Related]
5. Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch.
Zhang N; Zhong R; Perez-Pinera P; Herradon G; Ezquerra L; Wang ZY; Deuel TF
Biochem Biophys Res Commun; 2006 May; 343(2):653-8. PubMed ID: 16554021
[TBL] [Abstract][Full Text] [Related]
6. An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis.
Choudhuri R; Zhang HT; Donnini S; Ziche M; Bicknell R
Cancer Res; 1997 May; 57(9):1814-9. PubMed ID: 9135027
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
[TBL] [Abstract][Full Text] [Related]
8. Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells.
Kawaguchi M; Hosotani R; Kogire M; Ida J; Doi R; Koshiba T; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Masui T; Imamura M
Int J Oncol; 2000 Jan; 16(1):37-41. PubMed ID: 10601546
[TBL] [Abstract][Full Text] [Related]
9. Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.
Grzelinski M; Bader N; Czubayko F; Aigner A
Int J Cancer; 2005 Dec; 117(6):942-51. PubMed ID: 15986444
[TBL] [Abstract][Full Text] [Related]
10. [Construction of the recombinant adenovirus mediated shRNA to silence PTN in pancreatic carcinoma and the effect of DRGn on neurite in vitro].
Yao J; Ma QY; Wang LC; Zhang M; Shen SG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Sep; 23(9):797-800. PubMed ID: 17825221
[TBL] [Abstract][Full Text] [Related]
11. Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells.
Zhu Z; Kleeff J; Kayed H; Wang L; Korc M; Büchler MW; Friess H
Mol Carcinog; 2002 Nov; 35(3):138-47. PubMed ID: 12410565
[TBL] [Abstract][Full Text] [Related]
12. Pleiotrophin, a multifunctional angiogenic factor: mechanisms and pathways in normal and pathological angiogenesis.
Perez-Pinera P; Berenson JR; Deuel TF
Curr Opin Hematol; 2008 May; 15(3):210-4. PubMed ID: 18391787
[TBL] [Abstract][Full Text] [Related]
13. Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth.
Czubayko F; Riegel AT; Wellstein A
J Biol Chem; 1994 Aug; 269(33):21358-63. PubMed ID: 8063762
[TBL] [Abstract][Full Text] [Related]
14. Pleiotrophin and midkine in normal development and tumor biology.
Kurtz A; Schulte AM; Wellstein A
Crit Rev Oncog; 1995; 6(2):151-77. PubMed ID: 8792088
[TBL] [Abstract][Full Text] [Related]
15. Pleiotrophin induces formation of functional neovasculature in vivo.
Christman KL; Fang Q; Kim AJ; Sievers RE; Fok HH; Candia AF; Colley KJ; Herradon G; Ezquerra L; Deuel TF; Lee RJ
Biochem Biophys Res Commun; 2005 Jul; 332(4):1146-52. PubMed ID: 15949466
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
Fukasawa M; Korc M
Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686
[TBL] [Abstract][Full Text] [Related]
18. Midkine and pleiotrophin in neural development and cancer.
Kadomatsu K; Muramatsu T
Cancer Lett; 2004 Feb; 204(2):127-43. PubMed ID: 15013213
[TBL] [Abstract][Full Text] [Related]
19. Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways.
Souttou B; Raulais D; Vigny M
J Cell Physiol; 2001 Apr; 187(1):59-64. PubMed ID: 11241349
[TBL] [Abstract][Full Text] [Related]
20. TIMP-1 antisense gene transfection attenuates the invasive potential of pancreatic cancer cells in vitro and inhibits tumor growth in vivo.
Bloomston M; Shafii A; Zervos E; Rosemurgy AS
Am J Surg; 2005 Jun; 189(6):675-9. PubMed ID: 15910719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
